LEADS BIOLABS-B (09887) Sees HK$669 Million in Deposited Securities; Major Shareholder Moves 9.71 Million Shares to Morgan Stanley HK

Stock News09-04 09:08

A recent filing with the Hong Kong Stock Exchange revealed a notable position change for LEADS BIOLABS-B (09887) on September 3rd. The company's total deposited market value reached HK$669 million, representing a 5.05% stake.

In this transaction, a shareholder transferred 9.71 million shares to Morgan Stanley's Hong Kong securities account, increasing their holding ratio by 4.92%. This shift signals a strategic repositioning of the company's share ownership.

Earlier, LEADS BIOLABS-B had published its interim results for the 2026 fiscal year, reporting revenue of RMB 35.969 million. The company's R&D expenses climbed by 44.92% year-over-year to approximately RMB 191 million, while administrative costs rose 15.5% to RMB 41.4 million. The company posted a net loss of around RMB 222 million for the period, representing a 33.38% increase compared to the prior year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment